PDS Biotechnology Statistics
Total Valuation
PDSB has a market cap or net worth of $99.06 million. The enterprise value is $97.83 million.
Important Dates
The last earnings date was Friday, November 13, 2026, before market open.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PDSB has 122.70 million shares outstanding. The number of shares has increased by 37.10% in one year.
| Current Share Class | 122.70M |
| Shares Outstanding | 122.70M |
| Shares Change (YoY) | +37.10% |
| Shares Change (QoQ) | +29.24% |
| Owned by Insiders (%) | 1.15% |
| Owned by Institutions (%) | 9.25% |
| Float | 48.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.57
| Current Ratio | 0.57 |
| Quick Ratio | 0.45 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.52 |
Financial Efficiency
Return on equity (ROE) is -543.97% and return on invested capital (ROIC) is -113.41%.
| Return on Equity (ROE) | -543.97% |
| Return on Assets (ROA) | -70.59% |
| Return on Invested Capital (ROIC) | -113.41% |
| Return on Capital Employed (ROCE) | 779.57% |
| Weighted Average Cost of Capital (WACC) | 15.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.54M |
| Employee Count | 21 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.33% in the last 52 weeks. The beta is 1.13, so PDSB's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | +2.33% |
| 50-Day Moving Average | 1.03 |
| 200-Day Moving Average | 0.84 |
| Relative Strength Index (RSI) | 39.14 |
| Average Volume (20 Days) | 5,043,857 |
Short Selling Information
The latest short interest is 3.52 million, so 2.87% of the outstanding shares have been sold short.
| Short Interest | 3.52M |
| Short Previous Month | 3.39M |
| Short % of Shares Out | 2.87% |
| Short % of Float | 7.31% |
| Short Ratio (days to cover) | 0.30 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -25.59M |
| Pretax Income | -32.28M |
| Net Income | -32.28M |
| EBITDA | -25.53M |
| EBIT | -25.59M |
| Earnings Per Share (EPS) | -$0.55 |
Full Income Statement Balance Sheet
The company has $5.60 million in cash and $4.36 million in debt, with a net cash position of $1.23 million or $0.01 per share.
| Cash & Cash Equivalents | 5.60M |
| Total Debt | 4.36M |
| Net Cash | 1.23M |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | -3.58M |
| Book Value Per Share | -0.06 |
| Working Capital | -5.33M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -16.78M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 60,518 |
| Net Borrowing | -19.90M |
| Free Cash Flow | -16.78M |
| FCF Per Share | -$0.14 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PDSB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -37.10% |
| Shareholder Yield | -37.10% |
| Earnings Yield | -68.06% |
| FCF Yield | -16.19% |
Analyst Forecast
The average price target for PDSB is $4.50, which is 457.41% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.50 |
| Price Target Difference | 457.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on March 18, 2019. It was a reverse split with a ratio of 1:20.
| Last Split Date | Mar 18, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |